Robert S. Swinney - 03 Jun 2021 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Director
Signature: By: Paula Darbyshire, Attorney-in-fact For: Robert S. Swinney, M.D.
Issuer symbol: ICUI
Transactions as of: 03 Jun 2021
Net transactions value: -$789,294
Form type: 4
Filing time: 03 Jun 2021, 18:38:25 UTC
Previous filing: 12 May 2021
Next filing: 15 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$65,430	+1,500	+6.1%	$43.62	25,973	03 Jun 2021	Direct
transaction	ICUI	Common Stock	Options Exercise	$59,070	+1,500	+5.8%	$39.38	27,473	03 Jun 2021	Direct
transaction	ICUI	Common Stock	Sale	$60,647	-300	-1.1%	$202.16	27,173	03 Jun 2021	Direct	F1, F2
transaction	ICUI	Common Stock	Sale	$504,621	-2,485	-9.1%	$203.07	24,688	03 Jun 2021	Direct	F1, F3
transaction	ICUI	Common Stock	Sale	$43,878	-215	-0.87%	$204.08	24,473	03 Jun 2021	Direct	F1, F4
transaction	ICUI	Common Stock	Sale	$262,412	-1,293	-5.3%	$202.95	23,180	03 Jun 2021	Direct	F1, F5
transaction	ICUI	Common Stock	Sale	$42,236	-207	-0.89%	$204.04	22,973	03 Jun 2021	Direct	F1, F6
holding	ICUI	Common Stock						1,125	03 Jun 2021	by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,500	-100%	$0.000000^*	0	03 Jun 2021	Common Stock	1,500	$39.38	Direct
transaction	ICUI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,500	-100%	$0.000000^*	0	03 Jun 2021	Common Stock	1,500	$43.62	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are Restricted Stock Units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.84 to $202.64, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.87 to $203.42, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.00 to $204.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.64 to $203.41, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.